ArticleJACC. Case reports2026
Surgical Tricuspid Valve Repair Resulting in Acquired Gerbode Defect: A Rare and Challenging Case.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- SecondaryJournal of clinical medicine · 2026Article
- Clinical Strategy for Gerbode Defects.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcquired Gerbode defect is a complication of cardiac surgery. Diagnostic challenges arise because of frequent mischaracterization as severe tricuspid regurgitation on imaging, often delaying definitive management. CASE SUMMARY: After undergoing surgical tricuspid valve repair, a patient developed an acquired Gerbode defect located in the membranous septum beneath the noncoronary cusp of the aortic valve. The defect remained undetected for over 3 years owing to misinterpretation of echocardiographic findings as severe tricuspid regurgitation. Comprehensive transesophageal echocardiography enabled accurate diagnosis and anatomical localization. DISCUSSION: The defect was successfully closed percutaneously under transesophageal echocardiographic and fluoroscopic guidance using a 6-mm Amplatzer atrial septal defect occluder device. The procedure resulted in complete closure of the shunt, with no residual defect or complications. TAKE-HOME MESSAGE: This case highlights the importance of advanced imaging for the diagnosis of elusive acquired Gerbode defects and demonstrates that percutaneous device closure is a safe and effective therapeutic option for this uncommon postsurgical complication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.